Partnership
Partnering for AI-Driven RNA-Targeting Therapeutics (ASOs & Small Molecules)
AI-native drug discovery company specializing in RNA Tx seeks partnerships to develop antisense oligonucleotides and small molecules.
Author
Founder & CEO
Fold AI
Sydney, Australia
BioAI professor, innovator, startup founder and investor
Partnership
Partnering for AI-Driven RNA-Targeting Therapeutics (ASOs & Small Molecules)
AI-native drug discovery company specializing in RNA Tx seeks partnerships to develop antisense oligonucleotides and small molecules.